Institutions / Eagle Health Investments LP

Eagle Health Investments LP

CIK 1842545 · Institution · as of Dec 31, 2025
Portfolio value
$455.06M
Positions
30
As of
Dec 31, 2025

Top holdings

Dec 31, 2025View all 30 →
CompanyClassValueShares% of portfolio
Argenx SE$52.75M62,73011.6%
ICON plc$45.02M247,0909.9%
Natera, Inc.$41.98M183,2649.2%
Insmed Inc$36.71M210,9008.1%
Illumina Inc$30.32M231,1616.7%
Guardant Health, Inc.$29.02M284,1006.4%
Neurocrine Biosciences Inc$23.09M162,8005.1%
BioMarin Pharmaceutical Inc$21.80M366,8124.8%
Fortrea Holdings Inc.$21.02M1,218,5604.6%
BridgeBio Pharma, Inc.$19.83M259,3004.4%
Scholar Rock Holding Corp$16.00M363,3003.5%
Exact Sciences Corp.$15.01M147,7503.3%
Terns Pharmaceuticals, Inc.$11.11M275,0902.4%
Kymera Therapeutics, Inc.$10.61M136,3002.3%
COMPASS Pathways plcCMPSADR$10.48M1,519,3882.3%
PROCEPT BioRobotics Corp$9.70M308,4342.1%
Revolution Medicines, Inc.$9.23M115,9002.0%
Legend Biotech CorpLEGNADR$8.88M408,6522.0%
Atai Beckley NV$6.86M1,678,4001.5%
Soleno Therapeutics, Inc.$6.26M135,1001.4%
Protagonist Therapeutics Inc$5.00M57,3001.1%
Uniqure NV$4.91M205,2471.1%
Praxis Precision Medicines, Inc.$4.41M14,9511.0%
Centessa Pharmaceuticals PLC$2.58M103,1000.6%
Intuitive Surgical Inc$2.49M4,3900.5%

Activity

Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.